(Q46726987)

24 December 2017

title

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy (English)

1 reference

24 December 2017

0 references

0 references

0 references

substance use disorder

1 reference

10

Emmanuel Stip

1 reference

24 December 2017

1

Stéphane Potvin

1 reference

24 December 2017

Edouard Kouassi

2

1 reference

24 December 2017

Olivier Lipp

3

1 reference

24 December 2017

Roch-Hugo Bouchard

4

1 reference

24 December 2017

Marc-André Roy

5

1 reference

24 December 2017

Marie-France Demers

6

1 reference

24 December 2017

Alain Gendron

7

1 reference

24 December 2017

Giuseppe Astarita

8

1 reference

24 December 2017

Daniele Piomelli

9

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

24 December 2017

Journal of Psychopharmacology

published in

1 reference

24 December 2017

volume

22

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

262-269

1 reference

24 December 2017

The effects of cannabinoids on the brain

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

The role of endocannabinoid transmission in cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Review of the validity and significance of cannabis withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Endocannabinoid system and alcohol addiction: pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Endocannabinoid signalling in the blood of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

A cannabinoid mechanism in relapse to cocaine seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Nutritional effects of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Treatment of schizophrenia and comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

The residual neuropsychological effects of cannabis: the current status of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Residual neuropsychologic effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Cannabis as a risk factor for psychosis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Exercise activates the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Receptor-dependent formation of endogenous cannabinoids in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Consequences of alcohol consumption on host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Brain reward circuitry: insights from unsensed incentives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

Does dopamine sensitization underlie the association between schizophrenia and drug abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083816

21 January 2018

Identifiers

DOI

10.1177/0269881107083816

1 reference

24 December 2017

1 reference

24 December 2017